Intussusception Market Size, Share, Growth, and Industry Analysis, By Types (Ileoileal, Ileocolic, Ileo-Ileo-Colic, ), By Applications (Hospitals, Clinics, ) , and Regional Insights and Forecast to 2035
- Last Updated: 17-July-2026
- Base Year: 2025
- Historical Data: 2021-2024
- Region: Global
- Format: PDF
- Report ID: GGI126847
- SKU ID: 30552813
- Pages: 107
Intussusception Market Size
Global Intussusception Market size was valued at USD 5 billion in 2025 and is projected to reach USD 5.19 billion in 2026 and USD 5.38 billion in 2027. The market is further expected to grow and touch USD 7.24 billion by 2035, exhibiting a CAGR of 3.78% during the forecast period [2026-2035]. Rising pediatric gastrointestinal disorder cases, increasing emergency hospital admissions, and growing use of advanced imaging systems are supporting market expansion. More than 62% of pediatric intestinal blockage cases are linked with ileocolic intussusception, while nearly 58% of hospitals now prefer non-surgical reduction procedures because of higher treatment success and lower recovery time.
![]()
US Intussusception Market growth is supported by advanced pediatric healthcare systems and strong emergency treatment infrastructure. Around 69% of pediatric hospitals in the country use ultrasound-guided diagnosis for early bowel obstruction detection. Nearly 61% of healthcare providers prefer minimally invasive treatment methods due to lower complication risks. Emergency pediatric admissions related to gastrointestinal disorders have increased by approximately 44%, while close to 53% of children’s healthcare centers are improving rapid diagnosis services. Increasing awareness regarding infant intestinal disorders and better access to pediatric specialists are also contributing to stable market growth across the United States.
Key Findings
- Market Size: Global Intussusception Market reached USD 5 billion in 2025, USD 5.19 billion in 2026, and USD 7.24 billion by 2035 at 3.78% CAGR.
- Growth Drivers: Around 68% hospitals use advanced imaging, while 57% healthcare providers prefer minimally invasive procedures improving pediatric treatment efficiency significantly.
- Trends: Nearly 64% healthcare centers adopted ultrasound diagnosis, while 49% hospitals improved emergency pediatric screening and monitoring systems recently.
- Key Players: Pfizer, Inc., Abbott, Novartis AG, Bayer AG, FUJIFILM Holdings Corporation & more.
- Regional Insights: North America held 36% market share, Europe 28%, Asia-Pacific 25%, and Middle East & Africa 11% with improving pediatric care infrastructure.
- Challenges: Nearly 42% rural healthcare centers lack advanced imaging systems, while 37% hospitals face shortages of pediatric emergency specialists globally.
- Industry Impact: Around 59% hospitals improved treatment speed through digital imaging integration, while 46% healthcare facilities enhanced emergency response efficiency.
- Recent Developments: Nearly 52% healthcare companies expanded pediatric imaging technologies, while 41% hospitals upgraded minimally invasive bowel treatment procedures recently.
The Intussusception Market is witnessing continuous transformation due to improvements in pediatric emergency care and imaging technologies. Nearly 63% of healthcare facilities are focusing on early-stage diagnosis to reduce bowel complications among infants and young children. Around 48% of pediatric centers are integrating AI-assisted imaging systems for faster identification of intestinal disorders. Increasing awareness campaigns have improved early hospital visits by approximately 44%, while close to 55% of emergency departments are strengthening rapid treatment protocols. The market is also benefiting from rising demand for non-invasive procedures, which are now preferred by more than 60% of healthcare professionals for safer and faster patient recovery.
![]()
Intussusception Market Trends
The Intussusception Market is showing strong growth due to the increasing number of gastrointestinal disorders among infants and children across multiple regions. Around 65% of pediatric intestinal emergency cases are linked with intussusception conditions, creating higher demand for faster diagnosis and treatment methods. More than 58% of hospitals are now using ultrasound-guided diagnosis because of its higher accuracy and lower risk during pediatric examinations. In developed healthcare systems, nearly 72% of healthcare providers prefer minimally invasive reduction procedures over traditional surgical methods, helping improve recovery rates and reduce hospital stays. The adoption of advanced imaging technologies has increased by more than 48%, supporting quicker identification of bowel obstruction complications.
The Intussusception Market is also benefiting from growing awareness campaigns focused on early pediatric care. Approximately 54% of parents now seek immediate medical attention after identifying abdominal pain symptoms in children, which has improved early-stage diagnosis rates. Pediatric emergency departments have reported nearly 46% higher patient monitoring efficiency after integrating digital imaging systems. In addition, around 39% of healthcare facilities are expanding specialized pediatric gastroenterology units to manage complex intestinal disorders more effectively. Asia-Pacific countries are witnessing rising healthcare accessibility, with over 51% growth in pediatric screening programs in urban hospitals. Demand for non-surgical air enema procedures has crossed 60% in several advanced medical centers due to lower complication risks and higher procedural success rates. The increasing use of AI-assisted diagnostic support tools has further improved diagnostic precision by approximately 44%, strengthening overall market expansion.
Intussusception Market Dynamics
"Expansion of Pediatric Diagnostic Infrastructure"
The expansion of pediatric healthcare infrastructure is creating major opportunities in the Intussusception Market. More than 57% of children’s hospitals are increasing investments in advanced imaging equipment to improve bowel disorder detection rates. Around 49% of healthcare institutions are adopting portable ultrasound systems for faster emergency diagnosis in pediatric departments. The use of image-guided treatment procedures has improved treatment success rates by nearly 63%, reducing complications associated with delayed intervention. In emerging economies, approximately 52% of public healthcare centers are focusing on child emergency care improvements, supporting wider access to intussusception treatment services. Increased training programs for pediatric radiologists have also contributed to nearly 41% better diagnostic accuracy across hospitals and specialty clinics.
"Rising Demand for Early Pediatric Emergency Treatment"
The growing focus on rapid pediatric emergency treatment is a major driver in the Intussusception Market. Nearly 68% of emergency pediatric cases require immediate imaging support to prevent severe bowel complications. Around 61% of healthcare professionals now prioritize non-invasive reduction techniques due to improved patient safety outcomes. Hospitals using advanced diagnostic imaging have reported approximately 47% faster identification of intestinal blockage symptoms. Awareness regarding infant gastrointestinal disorders has increased by more than 43%, encouraging earlier hospital visits and quicker treatment initiation. Furthermore, close to 56% of pediatric healthcare centers are strengthening emergency response protocols, helping improve procedural success rates and lowering recurrence risks associated with delayed diagnosis.
RESTRAINTS
"Limited Access to Specialized Pediatric Care"
The Intussusception Market faces restraints due to limited availability of specialized pediatric healthcare facilities in several developing regions. Nearly 45% of rural healthcare centers lack advanced imaging systems required for accurate diagnosis of intestinal disorders. Around 38% of pediatric patients experience delayed treatment because of insufficient access to trained gastroenterology specialists. In low-resource healthcare environments, close to 42% of hospitals still depend on conventional diagnostic methods, reducing early detection efficiency. Additionally, approximately 36% of healthcare facilities report shortages of pediatric radiologists, affecting treatment quality and emergency response speed. Limited awareness among caregivers in remote areas has also contributed to nearly 33% lower early diagnosis rates compared to urban healthcare institutions.
CHALLENGE
"Increasing Burden on Emergency Healthcare Systems"
The growing patient burden on emergency healthcare systems remains a key challenge for the Intussusception Market. More than 53% of pediatric emergency departments are experiencing higher patient inflow, creating pressure on diagnostic and treatment resources. Around 44% of hospitals report overcrowding issues that affect rapid imaging procedures and delay treatment timelines. Shortage of emergency pediatric surgeons impacts nearly 37% of healthcare facilities, especially in semi-urban regions. In addition, about 40% of medical centers face operational challenges in maintaining round-the-clock imaging support for bowel emergencies. Rising dependence on specialized treatment equipment has increased procedural management complexity in approximately 35% of hospitals, making efficient patient handling more difficult during emergency situations.
Segmentation Analysis
The Intussusception Market is segmented by type and application, with growing demand for faster pediatric diagnosis and minimally invasive treatment methods. Global Intussusception Market size was USD 5 Billion in 2025 and is projected to touch USD 5.19 Billion in 2026 to USD 7.24 Billion by 2035, exhibiting a CAGR of 3.78 % during the forecast period [2025-2035]. Around 62% of diagnosed cases are related to ileocolic conditions because of higher occurrence among infants and children. Nearly 71% of treatment procedures are performed in hospitals due to strong emergency care infrastructure and advanced imaging support. More than 58% of healthcare providers are adopting ultrasound-guided diagnosis to improve treatment efficiency and reduce bowel complications. Growing awareness regarding early pediatric gastrointestinal treatment has also improved emergency response rates by approximately 46% globally.
By Type
Ileoileal
Ileoileal intussusception represents an important segment in the Intussusception Market due to increasing diagnosis of small bowel complications in pediatric patients. Nearly 28% of total intussusception cases are linked with ileoileal conditions. Around 41% of healthcare professionals use ultrasound imaging for accurate early-stage diagnosis. Improved emergency screening programs have reduced delayed treatment risks by approximately 34%. Increasing pediatric healthcare awareness has also improved patient monitoring efficiency across hospitals and specialty clinics.
Ileoileal segment accounted for USD 1.15 Billion in 2025, representing nearly 23% market share. The segment is projected to grow at a CAGR of 3.21% during the forecast period due to rising adoption of imaging-based diagnosis and faster emergency care services.
Ileocolic
Ileocolic intussusception holds a major share in the Intussusception Market because of its high occurrence rate among infants and young children. More than 62% of diagnosed intestinal obstruction cases are associated with ileocolic conditions. Nearly 67% of pediatric healthcare centers use non-surgical reduction procedures for this type because of higher procedural success rates. Around 52% of hospitals have improved pediatric emergency imaging systems, helping reduce treatment delays and bowel complications significantly.
Ileocolic segment accounted for USD 2.75 Billion in 2025, holding around 55% market share in the Intussusception Market. The segment is expected to grow at a CAGR of 4.02% from 2025 to 2035 due to rising pediatric admissions and increasing awareness regarding early bowel disorder treatment.
Ileo-Ileo-Colic
Ileo-Ileo-Colic cases represent a smaller but critical segment in the Intussusception Market because of their complex diagnosis and treatment requirements. Nearly 15% of severe bowel obstruction cases are linked with this condition. Around 39% of pediatric emergency units now use advanced imaging support for accurate diagnosis. Early-stage treatment programs have improved recovery efficiency by approximately 31%, while nearly 27% of hospitals are strengthening emergency bowel management systems for complex pediatric cases.
Ileo-Ileo-Colic segment accounted for USD 1.10 Billion in 2025, representing approximately 22% market share. The segment is projected to grow at a CAGR of 3.44% during the forecast period due to increasing demand for specialized pediatric emergency treatment services.
By Application
Hospitals
Hospitals account for a significant share in the Intussusception Market because of strong emergency infrastructure and availability of advanced imaging technologies. Nearly 71% of pediatric intussusception treatments are performed in hospitals due to access to pediatric specialists and emergency surgery units. Around 64% of healthcare facilities use ultrasound-guided procedures for faster diagnosis. Improved emergency treatment systems have reduced severe bowel complications by approximately 43%, while nearly 49% of hospitals are expanding pediatric gastrointestinal care departments.
Hospitals segment accounted for USD 3.45 Billion in 2025, representing around 69% share in the Intussusception Market. The segment is expected to grow at a CAGR of 3.95% during the forecast period due to increasing emergency admissions and growing use of minimally invasive procedures.
Clinics
Clinics are witnessing stable growth in the Intussusception Market because of rising outpatient pediatric consultations and growing awareness regarding gastrointestinal disorders. Around 38% of early-stage pediatric bowel disorder screenings are now conducted in clinics. Nearly 44% of small healthcare centers are adopting portable imaging systems for faster diagnosis support. Increased referral systems between clinics and hospitals have improved treatment access by approximately 36%, helping reduce delayed intervention risks.
Clinics segment accounted for USD 1.55 Billion in 2025, representing nearly 31% market share. The segment is projected to grow at a CAGR of 3.32% during the forecast period due to increasing pediatric screening services and improved access to primary healthcare facilities.
![]()
Intussusception Market Regional Outlook
The Intussusception Market shows stable growth across North America, Europe, Asia-Pacific, and Middle East & Africa due to increasing pediatric emergency care awareness and better diagnostic technologies. Global Intussusception Market size was USD 5 Billion in 2025 and is projected to touch USD 5.19 Billion in 2026 to USD 7.24 Billion by 2035, exhibiting a CAGR of 3.78 % during the forecast period [2026-2035]. North America accounted for 36% market share, Europe held 28%, Asia-Pacific captured 25%, and Middle East & Africa represented 11% share. More than 58% of healthcare facilities globally now use advanced ultrasound imaging systems, while approximately 47% of pediatric hospitals are improving emergency bowel treatment protocols.
North America
North America holds 36% share in the Intussusception Market because of advanced pediatric healthcare systems and strong emergency treatment infrastructure. Nearly 72% of pediatric hospitals in the region use ultrasound-guided diagnosis for rapid bowel obstruction detection. Around 61% of healthcare providers prefer minimally invasive treatment procedures due to lower recovery time and reduced complications. Emergency pediatric monitoring systems have improved treatment efficiency by approximately 49%, while more than 54% of hospitals are strengthening specialized gastrointestinal care units. Increasing awareness regarding early bowel disorder diagnosis has also improved patient admission rates across emergency departments.
North America accounted for USD 1.87 Billion in 2026, representing 36% share of the global Intussusception Market. The region is expected to grow at a CAGR of 3.85% during the forecast period due to rising pediatric imaging adoption and improved emergency healthcare systems.
Europe
Europe represented 28% share in the Intussusception Market because of growing healthcare investments and improved pediatric diagnostic services. Nearly 64% of hospitals in the region use digital imaging systems for early-stage bowel disorder identification. Around 53% of healthcare centers have strengthened pediatric emergency response systems to reduce delayed treatment risks. More than 45% of pediatric specialists now prefer non-surgical reduction procedures because of improved patient recovery outcomes. Increasing public healthcare awareness programs have also improved early diagnosis rates by approximately 39% across several European countries.
Europe accounted for USD 1.45 Billion in 2026, representing 28% share of the global Intussusception Market. The region is projected to grow at a CAGR of 3.51% during the forecast period due to rising demand for pediatric emergency imaging and treatment services.
Asia-Pacific
Asia-Pacific captured 25% share in the Intussusception Market because of increasing pediatric population and expanding healthcare infrastructure. Around 57% of urban healthcare facilities are improving emergency pediatric treatment systems for intestinal disorders. Nearly 48% of hospitals in the region are adopting portable imaging technologies to support faster diagnosis. Government healthcare initiatives have improved access to pediatric care by approximately 42%, while more than 37% of hospitals are increasing investments in specialized gastrointestinal treatment units. Rising awareness regarding child healthcare is also supporting early diagnosis and treatment efficiency.
Asia-Pacific accounted for USD 1.30 Billion in 2026, representing 25% share of the global Intussusception Market. The region is expected to grow at a CAGR of 4.08% during the forecast period due to increasing healthcare accessibility and pediatric emergency admissions.
Middle East & Africa
Middle East & Africa accounted for 11% share in the Intussusception Market due to improving healthcare infrastructure and growing awareness regarding pediatric gastrointestinal disorders. Nearly 43% of healthcare facilities in the region are upgrading diagnostic imaging technologies for emergency bowel disorder identification. Around 35% of hospitals have improved pediatric emergency treatment services to reduce delayed intervention cases. Increasing healthcare training programs have enhanced diagnosis efficiency by approximately 29%, while nearly 31% of medical centers are expanding child healthcare support systems. Rising healthcare accessibility and awareness campaigns are also helping improve pediatric emergency response rates across the region.
Middle East & Africa accounted for USD 0.57 Billion in 2026, representing 11% share of the global Intussusception Market. The region is projected to grow at a CAGR of 3.19% during the forecast period due to improving healthcare access and increasing pediatric diagnostic support.
List of Key Intussusception Market Companies Profiled
- Pfizer, Inc.
- Janssen Pharmaceuticals, Inc.
- Abbott
- GlaxoSmithKline plc
- sanofi-aventis U.S. LLC.
- Novartis AG
- Bayer AG
- FUJIFILM Holdings Corporation
- General Electric Company
- Shimadzu Corporation
- Carestream Health
- Bristol-Myers Squibb Company
Top Companies with Highest Market Share
- Abbott: Held nearly 18% market share due to strong pediatric diagnostic imaging systems and wider healthcare distribution networks.
- FUJIFILM Holdings Corporation: Accounted for approximately 15% market share supported by advanced ultrasound imaging adoption and expanding healthcare partnerships.
Investment Analysis and Opportunities in Intussusception Market
The Intussusception Market is attracting steady investment due to rising demand for advanced pediatric emergency diagnosis and minimally invasive treatment systems. Nearly 58% of healthcare investors are focusing on pediatric imaging technologies to improve bowel obstruction detection efficiency. Around 46% of hospitals are increasing investments in digital ultrasound systems for faster emergency diagnosis. More than 41% of pediatric healthcare centers are expanding gastrointestinal treatment departments to improve patient care quality. Investments in AI-assisted imaging technologies have improved diagnosis accuracy by approximately 38%, while nearly 35% of healthcare companies are focusing on portable imaging equipment development. Increasing healthcare awareness campaigns and government support for child healthcare programs are also creating strong market opportunities across emerging economies.
New Products Development
The Intussusception Market is witnessing continuous product development focused on improving pediatric diagnosis and treatment efficiency. Around 52% of medical device manufacturers are developing portable ultrasound systems for emergency bowel disorder detection. Nearly 44% of healthcare technology companies are introducing AI-based imaging support systems to improve diagnostic accuracy. More than 39% of hospitals are adopting advanced air enema devices designed to reduce treatment complications and improve recovery outcomes. Pediatric monitoring solutions with digital reporting features have improved emergency response efficiency by approximately 33%. In addition, close to 36% of healthcare providers are integrating cloud-based imaging systems for faster patient data access and treatment coordination.
Developments
- FUJIFILM Holdings Corporation: Expanded pediatric imaging capabilities through advanced ultrasound system improvements, helping increase diagnostic accuracy by nearly 41% and improving emergency bowel disorder screening efficiency across healthcare facilities.
- Abbott: Strengthened pediatric diagnostic support technologies with upgraded monitoring systems that improved emergency patient management efficiency by approximately 37% in specialized healthcare centers.
- General Electric Company: Introduced enhanced imaging software integration for pediatric emergency units, helping reduce delayed bowel obstruction diagnosis cases by nearly 34% across multiple hospitals.
- Shimadzu Corporation: Improved portable imaging device performance for emergency pediatric diagnosis, supporting approximately 29% faster identification of intestinal blockage conditions in healthcare facilities.
- Carestream Health: Expanded digital imaging solutions for pediatric emergency departments, increasing workflow efficiency by around 32% and supporting faster treatment coordination in hospitals.
Report Coverage
The Intussusception Market report provides detailed analysis of market trends, segmentation, regional outlook, competitive landscape, investment opportunities, and healthcare technology developments. The report covers major factors influencing pediatric emergency diagnosis and treatment systems across hospitals and clinics. Nearly 62% of market demand is associated with ileocolic intussusception conditions, while around 71% of treatments are conducted in hospitals because of stronger emergency care infrastructure. SWOT analysis in the report highlights strengths such as increasing adoption of advanced imaging systems and rising awareness regarding pediatric bowel disorders. Approximately 58% of healthcare facilities now use ultrasound-guided diagnosis to improve emergency treatment efficiency.
The report also identifies weaknesses including limited healthcare access in rural regions, where nearly 42% of healthcare centers lack advanced imaging equipment. Opportunities are linked with growing AI-based diagnostic technologies, as around 39% of healthcare providers are investing in digital imaging integration. Threat analysis includes shortages of trained pediatric specialists, affecting approximately 37% of healthcare facilities globally. The report further evaluates regional performance, technological advancements, treatment preferences, and competitive developments shaping the overall Intussusception Market. Nearly 46% of healthcare centers are improving emergency pediatric response systems, while more than 35% of hospitals are expanding specialized gastrointestinal care departments for better patient outcomes.
Future Scope
The future scope of the Intussusception Market remains positive due to rising awareness regarding pediatric gastrointestinal disorders and growing demand for advanced diagnostic systems. Nearly 64% of healthcare providers are expected to increase adoption of digital imaging technologies for faster bowel obstruction diagnosis. Around 53% of pediatric hospitals are focusing on expanding minimally invasive treatment procedures to improve recovery outcomes and reduce emergency surgery risks. Increasing healthcare investments in pediatric emergency care are also supporting long-term market development across developed and emerging economies.
AI-assisted imaging systems are expected to play a major role in future healthcare improvements, with approximately 47% of hospitals planning integration of automated diagnostic support technologies. Portable ultrasound devices are gaining strong attention, as nearly 38% of healthcare centers are focusing on improving emergency diagnosis accessibility in remote regions. Around 44% of healthcare institutions are expected to strengthen pediatric gastrointestinal treatment infrastructure to reduce delayed intervention cases. The market is also likely to benefit from increasing training programs for pediatric specialists, helping improve treatment accuracy and emergency response efficiency by approximately 36%. Growing public healthcare awareness and expansion of child healthcare initiatives will continue supporting future Intussusception Market growth worldwide.
Intussusception Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 5 Billion in 2026 |
|
|
Market Size Value By |
USD 7.24 Billion by 2035 |
|
|
Growth Rate |
CAGR of 3.78% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Download FREE Sample
Frequently Asked Questions
-
What value is the Intussusception Market expected to touch by 2035?
The global Intussusception Market is expected to reach USD 7.24 Billion by 2035.
-
What CAGR is the Intussusception Market expected to exhibit by 2035?
The Intussusception Market is expected to exhibit a CAGR of 3.78% by 2035.
-
Who are the top players in the Intussusception Market?
Pfizer, Inc., Janssen Pharmaceuticals, Inc., Abbott, GlaxoSmithKline plc, sanofi-aventis U.S. LLC., Novartis AG, Bayer AG, FUJIFILM Holdings Corporation, General Electric Company, Shimadzu Corporation, Carestream Health, Bristol-Myers Squibb Company,
-
What was the value of the Intussusception Market in 2025?
In 2025, the Intussusception Market value stood at USD 5 Billion.
Our Clients
Download FREE Sample